Torp-Pedersen C - Search Results

1

Gastrointestinal bleeding with direct oral anticoagulants in patients with atrial fibrillation and anaemia.

Al-Hussainy N, Kragholm KH, Lundbye-Christensen S, Torp-Pedersen C, Pareek M, Therkelsen SK, Lip GYH, Riahi S. Al-Hussainy N, et al. Thromb Res. 2023 Dec;232:62-69. doi: 10.1016/j.thromres.2023.10.013. Epub 2023 Oct 29. Thromb Res. 2023. PMID: 37939578 Free article.

2

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.

Olesen JB, Lip GY, Hansen ML, Hansen PR, Tolstrup JS, Lindhardsen J, Selmer C, Ahlehoff O, Olsen AM, Gislason GH, Torp-Pedersen C. Olesen JB, et al. BMJ. 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124. BMJ. 2011. PMID: 21282258 Free PMC article.

3

Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort.

Olesen JB, Lip GY, Hansen PR, Lindhardsen J, Ahlehoff O, Andersson C, Weeke P, Hansen ML, Gislason GH, Torp-Pedersen C. Olesen JB, et al. J Thromb Haemost. 2011 Aug;9(8):1460-7. doi: 10.1111/j.1538-7836.2011.04378.x. J Thromb Haemost. 2011. PMID: 21624047 Free article.

4

Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.

Olesen JB, Lip GY, Lindhardsen J, Lane DA, Ahlehoff O, Hansen ML, Raunsø J, Tolstrup JS, Hansen PR, Gislason GH, Torp-Pedersen C. Olesen JB, et al. Thromb Haemost. 2011 Oct;106(4):739-49. doi: 10.1160/TH11-05-0364. Epub 2011 Jul 20. Thromb Haemost. 2011. PMID: 21789337

5

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.

Banerjee A, Lane DA, Torp-Pedersen C, Lip GY. Banerjee A, et al. Thromb Haemost. 2012 Mar;107(3):584-9. doi: 10.1160/TH11-11-0784. Epub 2011 Dec 21. Thromb Haemost. 2012. PMID: 22186961

6

Atrial fibrillation and vascular disease--a bad combination.

Olesen JB, Gislason GH, Torp-Pedersen C, Lip GY. Olesen JB, et al. Clin Cardiol. 2012 Jan;35 Suppl 1(Suppl 1):15-20. doi: 10.1002/clc.20955. Clin Cardiol. 2012. PMID: 22246947 Free PMC article. Review.

7

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY. Olesen JB, et al. Thromb Haemost. 2012 Jun;107(6):1172-9. doi: 10.1160/TH12-03-0175. Epub 2012 Apr 3. Thromb Haemost. 2012. PMID: 22473219

8

Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.

Olesen JB, Lip GY, Lane DA, Køber L, Hansen ML, Karasoy D, Hansen CM, Gislason GH, Torp-Pedersen C. Olesen JB, et al. Am J Med. 2012 Aug;125(8):826.e13-23. doi: 10.1016/j.amjmed.2011.11.024. Epub 2012 May 10. Am J Med. 2012. PMID: 22579139

9

Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study.

Mikkelsen AP, Lindhardsen J, Lip GY, Gislason GH, Torp-Pedersen C, Olesen JB. Mikkelsen AP, et al. J Thromb Haemost. 2012 Sep;10(9):1745-51. doi: 10.1111/j.1538-7836.2012.04853.x. J Thromb Haemost. 2012. PMID: 22805071 Free article.

10

Stroke and bleeding in atrial fibrillation with chronic kidney disease.

Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C. Olesen JB, et al. N Engl J Med. 2012 Aug 16;367(7):625-35. doi: 10.1056/NEJMoa1105594. N Engl J Med. 2012. PMID: 22894575 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,457 results

Search Page

Filters